{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:53:14Z","timestamp":1762869194650,"version":"build-2065373602"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009928","name":"Higher Committee for Education Development in Iraq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009928","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.cellsig.2023.110885","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T11:42:30Z","timestamp":1694432550000},"page":"110885","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Fenretinide induces apoptosis and synergises the apoptosis inducing effect of gemcitabine through inhibition of key signalling molecules involved in A549 cell survival in in silico and in vitro analyses"],"prefix":"10.1016","volume":"111","author":[{"given":"Hazem A.","family":"Al-Bustany","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hawzheen A.","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud A.","family":"Chawsheen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phil R.","family":"Dash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2023.110885_bb0005","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.stem.2014.02.006","article-title":"Evolution of the cancer stem cell model","volume":"14","author":"Kreso","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.cellsig.2023.110885_bb0010","doi-asserted-by":"crossref","first-page":"7731","DOI":"10.3390\/ijms22147731","article-title":"Retinoids as chemo-preventive and molecular-targeted anti-cancer therapies","volume":"22","author":"Hunsu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2023.110885_bb0015","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1007\/s10495-006-9289-3","article-title":"Mechanisms of fenretinide-induced apoptosis","volume":"11","author":"Hail","year":"2006","journal-title":"Apoptosis"},{"key":"10.1016\/j.cellsig.2023.110885_bb0020","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1177\/1535370217706952","article-title":"Clinical development of fenretinide as an antineoplastic drug: pharmacology perspectives","volume":"242","author":"Cooper","year":"2017","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.cellsig.2023.110885_bb0025","first-page":"2699","article-title":"Approaches to prevention of epithelial cancer during the preneoplastic period","volume":"36","author":"Sporn","year":"1976","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2023.110885_bb0030","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2174\/1568009043333023","article-title":"Retinoids in cancer chemoprevention","volume":"4","author":"Okuno","year":"2004","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.cellsig.2023.110885_bb0035","first-page":"2032","article-title":"Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma","volume":"9","author":"Garaventa","year":"2003","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.cellsig.2023.110885_bb0040","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1002\/pbc.24643","article-title":"Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed\/refractory neuroblastoma: a report from the new approaches to neuroblastoma therapy (NANT) consortium","volume":"60","author":"Maurer","year":"2013","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.cellsig.2023.110885_bb0045","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00280-009-1228-x","article-title":"A phase II study of fenretinide in patients with hormone refractory prostate cancer: a trial of the cancer therapeutics research group","volume":"66","author":"Moore","year":"2010","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.cellsig.2023.110885_bb0050","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.bbamcr.2014.12.016","article-title":"Onconase induces autophagy sensitizing pancreatic cancer cells to gemcitabine and activates Akt\/mTOR pathway in a ROS-dependent manner","volume":"1853","author":"Fiorini","year":"2015","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"key":"10.1016\/j.cellsig.2023.110885_bb0055","article-title":"Fenretinide (4-HPR) targets caspase-9, ERK 1\/2 and the Wnt3a\/\u03b2-catenin pathway in medulloblastoma cells and medulloblastoma cell spheroids","volume":"11","author":"Castresana","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2023.110885_bb0060","doi-asserted-by":"crossref","DOI":"10.1530\/REM-22-0023","article-title":"Glutathione in cancer progression and chemoresistance: an update","volume":"2023","author":"Elda Valenti","year":"2023","journal-title":"Redox Exp. Med."},{"key":"10.1016\/j.cellsig.2023.110885_bb0065","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s10637-009-9228-6","article-title":"Phase II trial of fenretinide (NSC 374551) in patients with recurrent small cell lung cancer","volume":"27","author":"Schneider","year":"2009","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.cellsig.2023.110885_bb0070","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.cellsig.2023.110885_bb0075","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/0003-2697(77)90428-6","article-title":"A rapid, sensitive, and versatile assay for protein using coomassie brilliant blue G250","volume":"79","author":"Sedmak","year":"1977","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.cellsig.2023.110885_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.24271\/garmian.610","article-title":"Predicting the efficacy of Akt inhibitors using AutoDock Vina software","volume":"5","author":"Chawsheen","year":"2018","journal-title":"J. Garmian Univ."},{"key":"10.1016\/j.cellsig.2023.110885_bb0085","first-page":"47","article-title":"Docking study to predict the efficacy of phosphatidylinositol 3-kinase \u03b1 inhibitors","volume":"7","author":"Chawsheen","year":"2019","journal-title":"ARO Sci. J. Koya Univ."},{"key":"10.1016\/j.cellsig.2023.110885_bb0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/ars.2016.6769","article-title":"Dual inhibition of PI3K\/Akt and mTOR by the dietary antioxidant, delphinidin, ameliorates psoriatic features in vitro and in an imiquimod-induced psoriasis-like disease in mice","volume":"26","author":"Chamcheu","year":"2017","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.cellsig.2023.110885_bb0095","doi-asserted-by":"crossref","first-page":"7301","DOI":"10.1158\/0008-5472.CAN-05-1064","article-title":"Protein kinase C-epsilon regulates the apoptosis and survival of glioma cells","volume":"65","author":"Okhrimenko","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2023.110885_bb0100","doi-asserted-by":"crossref","first-page":"8366","DOI":"10.1158\/0008-5472.CAN-05-0553","article-title":"Protein kinase C epsilon is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy","volume":"65","author":"Pan","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2023.110885_bb0105","first-page":"8322","article-title":"Induction of glucose-regulated protein 78 by chronic hypoxia in human gastric tumor cells through a protein kinase C-epsilon\/ERK\/AP-1 signaling cascade","volume":"61","author":"Song","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2023.110885_bb0110","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1152\/physiolgenomics.00025.2005","article-title":"GAPDH as a housekeeping gene: analysis of GAPDH mRNA expression in a panel of 72 human tissues","volume":"21","author":"Barber","year":"2005","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.cellsig.2023.110885_bb0115","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1677\/jme.0.0250169","article-title":"Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays","volume":"25","author":"Bustin","year":"2000","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.cellsig.2023.110885_bb0120","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1530\/eje.0.1410169","article-title":"Norepinephrine, tri-iodothyronine and insulin upregulate glyceraldehyde-3-phosphate dehydrogenase mRNA during brown adipocyte differentiation","volume":"141","author":"Barroso","year":"1999","journal-title":"Eur. J. Endocrinol."},{"year":"2020","series-title":"Based on Proteomics Reveals the Anti-inflammatory Mechanism of Phillygenin by Inhibition NF-\u03baB Pathway,16 October 2020, Preprint (Version 1) Available at Research Square","author":"Zhou","key":"10.1016\/j.cellsig.2023.110885_bb0125"},{"key":"10.1016\/j.cellsig.2023.110885_bb0130","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1039\/C5MD00469A","article-title":"Isoindole-1,3-dione derivatives as RSK2 inhibitors: synthesis, molecular docking simulation and SAR analysis","volume":"7","author":"Zhou","year":"2016","journal-title":"MedChemComm"},{"key":"10.1016\/j.cellsig.2023.110885_bb0135","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.2174\/092986711796150531","article-title":"Fyn kinase in brain diseases and cancer: the search for inhibitors","volume":"18","author":"Schenone","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.cellsig.2023.110885_bb0140","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s10822-015-9835-6","article-title":"An SH2 domain model of STAT5 in complex with phospho-peptides define \u201cSTAT5 binding signatures\u201d","volume":"29","author":"Gianti","year":"2015","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.cellsig.2023.110885_bb0145","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.sbi.2006.10.007","article-title":"Protein-protein interactions in the allosteric regulation of protein kinases","volume":"16","author":"Pellicena","year":"2006","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.cellsig.2023.110885_bb0150","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cbi.2014.09.022","article-title":"4\u2019-demethyl-deoxypodophyllotoxin glucoside isolated from Podophyllum hexandrum exhibits potential anticancer activities by altering Chk-2 signaling pathway in MCF-7 breast cancer cells","volume":"224","author":"Zilla","year":"2014","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cellsig.2023.110885_bb0155","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.bmcl.2017.02.072","article-title":"Synthesis of novel 1,2,4-triazine scaffold as FAK inhibitors with antitumor activity","volume":"27","author":"Dao","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.cellsig.2023.110885_bb0160","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/jhet.4196","article-title":"Convenient method for the synthesis of some novel chiral methyl 2-(2-oxo-2H -benzo[e][1,3]oxazin-3(4H)-yl)propanoate derivatives and biological evaluation of their antioxidant, cytotoxic, and molecular docking properties","volume":"58","author":"Matam","year":"2020","journal-title":"J. Heterocyclic Chem."},{"key":"10.1016\/j.cellsig.2023.110885_bb0165","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1080\/15384101.2017.1321180","article-title":"The human mitochondrial Hsp60 in the APO conformation forms a stable tetradecameric complex","volume":"16","author":"Enriquez","year":"2017","journal-title":"Cell Cycle"},{"key":"10.1016\/j.cellsig.2023.110885_bb0170","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1444-2906.2007.01382.x","article-title":"Insight into nucleotide and Ca2+binding to carp?-actin","volume":"73","author":"Ooi","year":"2007","journal-title":"Fish. Sci."},{"year":"2021","series-title":"Integrating Data Mining, Network Pharmacology, and Molecular Docking Verification to Investigate the Molecular Mechanism of Traditional Chinese Medicine Prescriptions for Treating Male Infertility","author":"Bai","key":"10.1016\/j.cellsig.2023.110885_bb0175"},{"key":"10.1016\/j.cellsig.2023.110885_bb0180","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1517\/13543784.12.11.1829","article-title":"Fenretinide: a prototype cancer prevention drug","volume":"12","author":"Malone","year":"2003","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.cellsig.2023.110885_bb0185","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.cellsig.2023.110885_bb0190","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"year":"2017","series-title":"Discovery Studio Modeling Environment","author":"Biovia","key":"10.1016\/j.cellsig.2023.110885_bb0195"},{"key":"10.1016\/j.cellsig.2023.110885_bb0200","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1093\/carcin\/bgs234","article-title":"Identification of mammalian target of rapamycin as a direct target of fenretinide both in vitro and in vivo","volume":"33","author":"Xie","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cellsig.2023.110885_bb0205","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1194\/jlr.M031427","article-title":"Fenretinide inhibited de novo ceramide synthesis and proinflammatory cytokines induced by Aggregatibacter actinomycetemcomitans","volume":"54","author":"Yu","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cellsig.2023.110885_bb0210","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1158\/1078-0432.CCR-08-2477","article-title":"The combined therapeutic effects of bortezomib and fenretinide on neuroblastoma cells involve endoplasmic reticulum stress response","volume":"15","author":"Pagnan","year":"2009","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.cellsig.2023.110885_bb0215","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1039\/C5MB00101C","article-title":"The PI3K\/AKT\/mTOR interactive pathway","volume":"11","author":"Ersahin","year":"2015","journal-title":"Mol. BioSyst."},{"key":"10.1016\/j.cellsig.2023.110885_bb0220","first-page":"293","article-title":"The impact of retinoic acid treatment on the sensitivity of neuroblastoma cells to fenretinide","volume":"27","author":"Armstrong","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.cellsig.2023.110885_bb0225","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1080\/14756366.2021.1937143","article-title":"New horizons in drug discovery of lymphocyte-specific protein tyrosine kinase (Lck) inhibitors: a decade review (2011\u22122021) focussing on structure-activity relationship (SAR) and docking insights","volume":"36","author":"Elkamhawy","year":"2021","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.cellsig.2023.110885_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101364","article-title":"The PI3K\/Akt\/mTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at the application of nanoparticles","volume":"18","author":"Sanaei","year":"2022","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.cellsig.2023.110885_bb0235","doi-asserted-by":"crossref","first-page":"21790","DOI":"10.3390\/ijms141121790","article-title":"Combination of fenretinide and selenite inhibits proliferation and induces apoptosis in ovarian cancer cells","volume":"14","author":"Liu","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2023.110885_bb0240","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/CAD.0b013e328360a921","article-title":"Combination of fenretinide and indole-3-carbinol results in synergistic cytotoxic activity inducing apoptosis against human breast cancer cells in vitro","volume":"24","author":"Cevatemre","year":"2013","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.cellsig.2023.110885_bb0245","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.2147\/DDDT.S221909","article-title":"A novel nanomicellar combination of fenretinide and lenalidomide shows marked antitumor activity in a neuroblastoma xenograft model","volume":"13","author":"Orienti","year":"2019","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.cellsig.2023.110885_bb0250","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0014-2999(03)01907-1","article-title":"Enhanced effectiveness of last generation antiblastic compounds vs. cisplatin on malignant pleural mesothelioma cell lines","volume":"473","author":"de Cupis","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cellsig.2023.110885_bb0255","doi-asserted-by":"crossref","DOI":"10.1186\/bcr2625","article-title":"Anti-tumor effects of retinoids combined with trastuzumab or tamoxifen in breast cancer cells: induction of apoptosis by retinoid\/trastuzumab combinations","volume":"12","author":"Koay","year":"2010","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.cellsig.2023.110885_bb0260","article-title":"Fenretinide targeting of human colon cancer sphere cells through cell cycle regulation and stress-responsive activities","author":"Liu","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.cellsig.2023.110885_bb0265","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00006676-200110000-00008","article-title":"Retinoic acid enhances the cytotoxic effects of gemcitabine and cisplatin in pancreatic adenocarcinoma cells","volume":"23","author":"Pettersson","year":"2001","journal-title":"Pancreas"},{"key":"10.1016\/j.cellsig.2023.110885_bb0270","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jbior.2019.03.003","article-title":"Diverse signaling mechanisms of mTOR complexes: mTORC1 and mTORC2 in forming a formidable relationship","volume":"72","author":"Jhanwar-Uniyal","year":"2019","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.cellsig.2023.110885_bb0275","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1158\/1535-7163.MCT-09-0798","article-title":"Antimitotic effect of the retinoid 4-oxo-fenretinide through inhibition of tubulin polymerization: a novel mechanism of retinoid growth-inhibitory activity","volume":"8","author":"Appierto","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.cellsig.2023.110885_bb0280","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/sj.cdd.4401242","article-title":"Fenretinide induces cytochrome c release, caspase 9 activation and apoptosis in the absence of mitochondrial membrane depolarisation","volume":"10","author":"Ulukaya","year":"2003","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cellsig.2023.110885_bb0285","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.biopha.2014.03.013","article-title":"Additive enhancement of apoptosis by TRAIL and fenretinide in metastatic breast cancer cells in vitro","volume":"68","author":"Ulukaya","year":"2014","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cellsig.2023.110885_bb0290","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/jcp.1108","article-title":"Role of AKT kinase in sphingosine-induced apoptosis in human hepatoma cells","volume":"188","author":"Chang","year":"2001","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.cellsig.2023.110885_bb0295","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1164\/rccm.200910-1487OC","article-title":"Increased proteolysis, myosin depletion, and atrophic AKT-FOXO signaling in human diaphragm disuse","volume":"183","author":"Levine","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cellsig.2023.110885_bb0300","doi-asserted-by":"crossref","first-page":"7779","DOI":"10.1038\/sj.onc.1204984","article-title":"The protein kinase PKB\/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change","volume":"20","author":"Yamaguchi","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.cellsig.2023.110885_bb0305","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-019-6477-4","article-title":"Bag-1 stimulates bad phosphorylation through activation of Akt and Raf kinases to mediate cell survival in breast cancer","volume":"19","author":"Kizilboga","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cellsig.2023.110885_bb0310","doi-asserted-by":"crossref","first-page":"4128","DOI":"10.1158\/1078-0432.CCR-07-5160","article-title":"Proapoptotic bad and bid protein expression predict survival in stages II and III colon cancers","volume":"14","author":"Sinicrope","year":"2008","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.cellsig.2023.110885_bb0315","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.freeradbiomed.2012.10.537","article-title":"T63, a new 4-arylidene curcumin analogue, induces cell cycle arrest and apoptosis through activation of the reactive oxygen species-FOXO3a pathway in lung cancer cells","volume":"53","author":"Liu","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cellsig.2023.110885_bb0320","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1210\/jc.2012-4085","article-title":"Clinical review: kinase inhibitors: adverse effects related to the endocrine system","volume":"98","author":"Lodish","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cellsig.2023.110885_bb0325","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/aps.2018.21","article-title":"Nrf2 mediates the resistance of human A549 and HepG2 cancer cells to boningmycin, a new antitumor antibiotic, in vitro through regulation of glutathione levels","volume":"39","author":"Zhang","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.cellsig.2023.110885_bb0330","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/annonc\/mdl047","article-title":"Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer","volume":"17","author":"Veronesi","year":"2006","journal-title":"Ann. Oncol.: Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.cellsig.2023.110885_bb0335","doi-asserted-by":"crossref","first-page":"15999","DOI":"10.1073\/pnas.1419057111","article-title":"Actions of the protein kinase WNK1 on endothelial cells are differentially mediated by its substrate kinases OSR1 and SPAK","volume":"111","author":"Dbouk","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cellsig.2023.110885_bb0340","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-020-2687-6","article-title":"\u03b2-Catenin promotes endothelial survival by regulating eNOS activity and flow-dependent anti-apoptotic gene expression","volume":"11","author":"Tajadura","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2023.110885_bb0345","article-title":"The JNK signaling pathway plays a key role in methuosis (non-apoptotic cell death) induced by MOMIPP in glioblastoma","volume":"19","author":"Li","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cellsig.2023.110885_bb0350","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2023.110885_bb0355","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1074\/jbc.M111.323709","article-title":"p38\u03b1 mediates cell survival in response to oxidative stress via induction of antioxidant genes","volume":"287","author":"Guti\u00e9rrez-Uzquiza","year":"2012","journal-title":"J. Biol. Chem."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656823003005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656823003005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:14:27Z","timestamp":1760267667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656823003005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":71,"alternative-id":["S0898656823003005"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2023.110885","relation":{},"ISSN":["0898-6568"],"issn-type":[{"type":"print","value":"0898-6568"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fenretinide induces apoptosis and synergises the apoptosis inducing effect of gemcitabine through inhibition of key signalling molecules involved in A549 cell survival in in silico and in vitro analyses","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2023.110885","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110885"}}